Presbycusis: Pathology, Signal Pathways, and Therapeutic Strategy

  • Xiaoxu Zhao
  • , Tian Shen
  • , Shengda Cao
  • , Ziyi Liu
  • , Wendu Pang
  • , Meixuan Li
  • , Jingjing Liu
  • , Wen Li
  • , Yunhao Wu
  • , Chengcheng Liu
  • , Ming Xia*
  • , Xiaolong Fu*
  • , Cheng Cheng*
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Presbycusis, also known as age-related hearing loss (ARHL), is a progressive auditory impairment and ranks among the most prevalent sensory disorders in the elderly population. It is primarily caused by damage to hair cells, degeneration of spiral ganglion neurons, and atrophy of the stria vascularis, which are integral components of the cochlea. While extensive research has been devoted to hair cells and spiral ganglion neurons, this review focuses on the critical role of the stria vascularis in ARHL. The primary function of the stria vascularis is to maintain the endocochlear potential, which is essential for hearing. This review presents an overview of the research concerning the stria vascularis in ARHL, particularly focusing on the application of single-cell transcriptomics to elucidate its role. Furthermore, this review explores relevant signaling pathways and therapeutic strategies for ARHL. By enhancing the understanding of the stria vascularis in ARHL, this review aims to pave the way for personalized treatment and improved strategies for protection and prevention.

Original languageEnglish
Article number2410413
JournalAdvanced Science
Volume12
Issue number29
DOIs
Publication statusPublished - 7 Aug 2025
Externally publishedYes

Keywords

  • pathology
  • presbycusis
  • single-cell transcriptomic therapeutic strategy
  • stria vascularis

Fingerprint

Dive into the research topics of 'Presbycusis: Pathology, Signal Pathways, and Therapeutic Strategy'. Together they form a unique fingerprint.

Cite this